Severe uncontrolled asthma in patients over 75 years old: Treatment with omalizumab

Revue des maladies respiratoires
P RomandG Devouassoux

Abstract

With an aging population and an increase in the prevalence of asthma, this disease is becoming more common in the elderly. Nevertheless, the management of severe asthma can be complex, due to an increased risk of uncontrolled disease in patients over 65 years old and partly to the inherent characteristics of old age: comorbidities, underestimation of the role of allergies, poor adherence, difficulties with inhalation devices, etc. We report two cases of women over 75 with severe persistent allergic asthma not controlled by high doses of inhaled corticosteroids and long-acting beta-2-agonists in whom treatment with omalizumab was initiated. Following treatment with omalizumab a decrease in the number and severity of exacerbations, improved asthma control and dose reduction or discontinuation of systemic corticosteroids were observed. The tolerance of omalizumab was good in both cases. Omalizumab is to be considered an effective and well-tolerated therapeutic option for elderly patients with inadequately controlled severe allergic asthma.

References

Jul 5, 2002·Respiration; International Review of Thoracic Diseases·Mahmoud Zureik, Jean Orehek
Apr 17, 2008·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Robert J MaykutGregory P Geba
Feb 23, 2010·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Andrzej Bozek, Jerzy Jarzab
Aug 3, 2010·The Journal of Allergy and Clinical Immunology·Charles E Reed
Oct 12, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Stephanie KornRoland Buhl
Jan 12, 2011·Respiratory Medicine·Nicola ScichiloneVincenzo Bellia
Mar 26, 2011·Respiratory Medicine·J HaughneyR Buhl
Dec 27, 2011·Allergy and Asthma Proceedings·Prashant VermaWilliam B Klaustermeyer
Jun 12, 2012·Revue des maladies respiratoires·M-C DelmasC Fuhrman
Mar 19, 2013·Chest·Lamiae Grimaldi-BensoudaUNKNOWN Pharmacoepidemiology of Asthma and Xolair (PAX) Study Group

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergies & Environmental Factors

Environmental factors are strongly associated with the prevalence of allergies and are an increasing health concern worldwide. Discover the latest research on Allergies and Environmental Factors here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.